| Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles N Pavlović, S Goločorbin-Kon, M Ðanić, B Stanimirov, H Al-Salami, ... Frontiers in Pharmacology 9, 411880, 2018 | 222 | 2018 |
| Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome M Ðanić, B Stanimirov, N Pavlović, S Goločorbin-Kon, H Al-Salami, ... Frontiers in pharmacology 9, 401908, 2018 | 120 | 2018 |
| Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases B Stanimirov, K Stankov, M Mikov | 59 | 2015 |
| Pleiotropic functions of bile acids mediated by the farnesoid X receptor B Stanimirov, K Stankov, M Mikov Acta gastro-enterologica Belgica 75 (4), 389-398, 2012 | 58 | 2012 |
| Potential applications of gliclazide in treating type 1 diabetes mellitus: formulation with bile acids and probiotics M Mikov, M Đanić, N Pavlović, B Stanimirov, S Goločorbin-Kon, K Stankov, ... European Journal of Drug Metabolism and Pharmacokinetics 43, 269-280, 2018 | 29 | 2018 |
| An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and Sweden N Pavlović, B Stanimirov, M Stojančević, M Paut-Kusturica, A Stoimenova, ... Biotechnology & Biotechnological Equipment 26 (5), 3236-3241, 2012 | 29 | 2012 |
| DPP-4 inhibitors: renoprotective potential and pharmacokinetics in type 2 diabetes mellitus patients with renal impairment M Mikov, N Pavlović, B Stanimirov, M Đanić, S Goločorbin-Kon, K Stankov, ... European journal of drug metabolism and pharmacokinetics 45 (1), 1-14, 2020 | 21 | 2020 |
| Bile acids as novel pharmacological agents: the interplay between gene polymorphisms, epigenetic factors and drug response N Pavlovic, B Stanimirov, M Mikov Current Pharmaceutical Design 23 (1), 187-215, 2017 | 19 | 2017 |
| The influence of bile salts on the distribution of simvastatin in the octanol/buffer system M Đanić, N Pavlović, B Stanimirov, S Vukmirović, K Nikolić, D Agbaba, ... Drug Development and Industrial Pharmacy 42 (4), 661-667, 2016 | 18 | 2016 |
| PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bile acids M Đanić, N Pavlović, B Stanimirov, S Lazarević, S Vukmirović, ... European Journal of Pharmaceutical Sciences 158, 105668, 2021 | 17 | 2021 |
| Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria M Djanic, N Pavlovic, B Stanimirov, T Stojancevic, S Golocorbin-Kon, ... Eur. Rev. Med. Pharmacol. Sci 20 (3), 553-560, 2016 | 15 | 2016 |
| The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes M Mikov, M Đanić, N Pavlović, B Stanimirov, S Goločorbin-Kon, K Stankov, ... European Journal of Drug Metabolism and Pharmacokinetics 42 (6), 881-890, 2017 | 14 | 2017 |
| Transport and biotransformation of gliclazide and the effect of deoxycholic acid in a probiotic bacteria model M Ðanić, B Stanimirov, N Pavlović, S Vukmirović, J Lazić, H Al-Salami, ... Frontiers in pharmacology 10, 1083, 2019 | 12 | 2019 |
| Phytol may inspire new medicinal foods for the treatment of heart disease B Pejin, T Kartali, B Stanimirović, M Karaman Asian Journal of Chemistry 26 (23), 8261-8262, 2014 | 9 | 2014 |
| In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders N Pavlović, M Đanić, B Stanimirov, S Goločorbin-Kon, K Stankov, ... Current Pharmaceutical Design 25 (35), 3776-3783, 2019 | 8 | 2019 |
| Pharmacogenomic determinants of response to cardiovascular drugs KM Stankov, BG Stanimirov, MM Mikov Medicinski pregled 68 (7-8), 259-265, 2015 | 8 | 2015 |
| Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions M Đanić, N Pavlović, S Lazarević, B Stanimirov, S Vukmirović, ... Frontiers in Pharmacology 14, 1111115, 2023 | 6 | 2023 |
| Alpha-tocopheryl succinate (α-TOS) influences cell vitality and enzyme activity in Ehrlich ascites carcinoma cells K Stankov, K Bajin-Katić, B Stanimirov, D Karadžić, Z Kovačević Archive of Oncology 15 (3-4), 65-68, 2007 | 5 | 2007 |
| Drug interference with biochemical laboratory tests J Katanić, B Stanimirov, V Sekeruš, M Đanić, N Pavlović, M Mikov, ... Biochemia Medica 33 (2), 2023 | 4 | 2023 |
| In vitro radioprotective activity of the bryozoan Hyalinella punctata B Pejin, B Stanimirović, NO Đorđević, AE Hegedis, IM Karaman, ... Asian Journal of Chemistry 25 (8), 4713-4714, 2013 | 4 | 2013 |
Momir MikovProfessor Pharmacology and Toxicology, Medical Faculty, University of Novi Sad, Serbia在 mf.uns.ac.rs 的电子邮件经过验证
